Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.
Open Access
- 23 May 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 34 (7), 529-533
- https://doi.org/10.1007/s40266-017-0469-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its OperationalizationThe Journals of Gerontology: Series A, 2016
- The Burden of Polypharmacy in Patients Near the End of LifeJournal of Pain and Symptom Management, 2015
- Reducing Inappropriate PolypharmacyJAMA Internal Medicine, 2015
- Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting IllnessJAMA Internal Medicine, 2015
- End-of-life management in patients with amyotrophic lateral sclerosisThe Lancet Neurology, 2015
- Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron diseasePublished by Wiley ,2013
- Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)Emergencias, 2012
- Discussions about treatment restrictions in chronic neurologic diseasesNeurology, 2012
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Managing comorbidities in patients at the end of lifeBMJ, 2004